List your tool

Head to head · 2026

Artera vs Oatmeal Health

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Artera

FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions

4.4Not listed

Visit Artera (opens Artera in a new tab)

Oatmeal Health

AI reads 3D low-dose CT scans and risk-stratifies lung nodules (AUROC 0.94, trained on 100,000+ scans)…

3.3Not listed

Visit Oatmeal Health (opens Oatmeal Health in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Artera does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Artera

    4.4 against 3.3

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onArteraOatmeal Health
Our rating4.4Better3.3
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Multimodal AI trained on digitized biopsy images paired with clinical data
  • FDA De Novo authorization for the ArteraAI Prostate Test
  • FDA clearance for ArteraAI Breast digital pathology risk stratification
  • Results delivered in as little as two days after sample submission
  • Inclusion in National Comprehensive Cancer Network (NCCN) treatment guidelines
  • AI risk-stratification of lung nodules from 3D low-dose CT
  • AUROC 0.94, trained on 100,000+ CT scans
  • Complements established Lung-RADS protocols
  • EHR-integrated high-risk patient identification
  • Live deployment across FQHCs in 4 U.S. states
Pros
  • Regulatory clearance (FDA De Novo, NCCN guideline inclusion) beyond most AI health startups
  • Published clinical evidence showing improved outcome prediction versus existing risk models
  • Adopted by a meaningful share of US prostate cancer clinicians already
  • Real, verifiable clinical deployment, not just a pilot announcement
  • Named technology partnership (Coreline Soft) and Google Cloud case study
  • Specifically targets underserved communities with limited screening access
Cons
  • Not a self-serve software product; access runs through labs, clinicians, and insurance billing
  • Pricing is not public and varies by payer and region
  • Limited to prostate and breast cancer currently, not a general oncology platform
  • LungAI is an investigational device and has not yet been cleared by the FDA - a 510(k) submission is targeted for Q1 2026
  • Institutional-only deployment, not accessible to individual patients directly
  • AI risk stratification supports, but doesn't replace, physician diagnosis and follow-up
CompanyArtera, founded 2021Oatmeal Health

Prices come from each vendor's pricing page, last checked 20260826. Check the vendor before you buy.

FAQ

Questions people ask

Is Artera better than Oatmeal Health?

In our reviews Artera scores 4.4 and Oatmeal Health scores 3.3. The better pick depends on the job. Artera: FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions. Oatmeal Health: AI reads 3D low-dose CT scans and risk-stratifies lung nodules (AUROC 0.94, trained on 100,000+ scans) - already deployed across underserved health centers in 4 states.

Which is cheaper, Artera or Oatmeal Health?

Artera: see pricing. Oatmeal Health: see pricing.

Do Artera and Oatmeal Health have free plans?

Neither lists a free plan.

More comparisons